HIV-1 group N among HIV-1-seropositive individuals in Cameroon.
Ayouba
A
A
Centre Pasteur du Cameroun, Laboratoire National de Santé Publique et de Reference, Yaoundé.
Souquières
S
S
Njinku
B
B
Martin
P M
PM
Müller-Trutwin
M C
MC
Roques
P
P
Barré-Sinoussi
F
F
Mauclère
P
P
Simon
F
F
Nerrienet
E
E
D000328:Adult; D002163:Cameroon / Q000453:epidemiology; D005260:Female; D015483:HIV Antibodies / Q000097:blood*; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D015658:HIV Infections / Q000821:virology*; D015497:HIV-1 / Q000145:classification*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000276:immunology; D012703:Serotyping / Q000379:methods
D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; C059762:HIV envelope protein gp120 (305-321); D010446:Peptide Fragments